83 related articles for article (PubMed ID: 37151990)
1. Self-replicating RNA nanoparticle vaccine elicits protective immune responses against SARS-CoV-2.
Lin G; Yan H; Sun J; Zhao J; Zhang Y
Mol Ther Nucleic Acids; 2023 Jun; 32():650-666. PubMed ID: 37151990
[TBL] [Abstract][Full Text] [Related]
2. Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primates.
Erasmus JH; Khandhar AP; Walls AC; Hemann EA; O'Connor MA; Murapa P; Archer J; Leventhal S; Fuller J; Lewis T; Draves KE; Randall S; Guerriero KA; Duthie MS; Carter D; Reed SG; Hawman DW; Feldmann H; Gale M; Veesler D; Berglund P; Fuller DH
bioRxiv; 2020 May; ():. PubMed ID: 32511417
[TBL] [Abstract][Full Text] [Related]
3. Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity.
Volpatti LR; Wallace RP; Cao S; Raczy MM; Wang R; Gray LT; Alpar AT; Briquez PS; Mitrousis N; Marchell TM; Sasso MS; Nguyen M; Mansurov A; Budina E; Solanki A; Watkins EA; Schnorenberg MR; Tremain AC; Reda JW; Nicolaescu V; Furlong K; Dvorkin S; Yu SS; Manicassamy B; LaBelle JL; Tirrell MV; Randall G; Kwissa M; Swartz MA; Hubbell JA
ACS Cent Sci; 2021 Aug; 7(8):1368-1380. PubMed ID: 34466656
[TBL] [Abstract][Full Text] [Related]
4. A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation.
Kimura T; Leal JM; Simpson A; Warner NL; Berube BJ; Archer JF; Park S; Kurtz R; Hinkley T; Nicholes K; Sharma S; Duthie MS; Berglund P; Reed SG; Khandhar AP; Erasmus JH
Mol Ther; 2023 Aug; 31(8):2360-2375. PubMed ID: 37403357
[TBL] [Abstract][Full Text] [Related]
5. Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity.
Volpatti LR; Wallace RP; Cao S; Raczy MM; Wang R; Gray LT; Alpar AT; Briquez PS; Mitrousis N; Marchell TM; Sasso MS; Nguyen M; Mansurov A; Budina E; Solanki A; Watkins EA; Schnorenberg MR; Tremain AC; Reda JW; Nicolaescu V; Furlong K; Dvorkin S; Yu SS; Manicassamy B; LaBelle JL; Tirrell MV; Randall G; Kwissa M; Swartz MA; Hubbell JA
bioRxiv; 2021 Apr; ():. PubMed ID: 33851166
[TBL] [Abstract][Full Text] [Related]
6. New Generation Self-Replicating RNA Vaccines Derived from Pestivirus Genome.
Démoulins T; Techakriengkrai N; Ebensen T; Schulze K; Liniger M; Gerber M; Nedumpun T; McCullough KC; Guzmán CA; Suradhat S; Ruggli N
Methods Mol Biol; 2024; 2786():89-133. PubMed ID: 38814391
[TBL] [Abstract][Full Text] [Related]
7. Activation and induction of antigen-specific T follicular helper cells play a critical role in recombinant SARS-CoV-2 RBD vaccine-induced humoral responses.
Yang S; Duan L; Wang C; Zhang C; Hou S; Wang H; Song J; Zhang T; Li Z; Wang M; Tang J; Zheng Q; Wang H; Wang Q; Zhao W
Mol Biomed; 2023 Oct; 4(1):34. PubMed ID: 37853288
[TBL] [Abstract][Full Text] [Related]
8. Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2.
Walls AC; Fiala B; Schäfer A; Wrenn S; Pham MN; Murphy M; Tse LV; Shehata L; O'Connor MA; Chen C; Navarro MJ; Miranda MC; Pettie D; Ravichandran R; Kraft JC; Ogohara C; Palser A; Chalk S; Lee EC; Kepl E; Chow CM; Sydeman C; Hodge EA; Brown B; Fuller JT; Dinnon KH; Gralinski LE; Leist SR; Gully KL; Lewis TB; Guttman M; Chu HY; Lee KK; Fuller DH; Baric RS; Kellam P; Carter L; Pepper M; Sheahan TP; Veesler D; King NP
bioRxiv; 2020 Aug; ():. PubMed ID: 32817941
[TBL] [Abstract][Full Text] [Related]
9. Ginseng Polysaccharide Enhances the Humoral and Cellular Immune Responses to SARS-CoV-2 RBD Protein Subunit Vaccines.
Zhang J; Feng J; Huang Y; Zhou B; Li B; Zhang R
Vaccines (Basel); 2023 Dec; 11(12):. PubMed ID: 38140237
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses.
Carmen JM; Shrivastava S; Lu Z; Anderson A; Morrison EB; Sankhala RS; Chen WH; Chang WC; Bolton JS; Matyas GR; Michael NL; Joyce MG; Modjarrad K; Currier JR; Bergmann-Leitner E; Malloy AMW; Rao M
NPJ Vaccines; 2021 Dec; 6(1):151. PubMed ID: 34903722
[TBL] [Abstract][Full Text] [Related]
11. Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines.
Kim B; Hosn RR; Remba T; Yun D; Li N; Abraham W; Melo MB; Cortes M; Li B; Zhang Y; Dong Y; Irvine DJ
J Control Release; 2023 Jan; 353():241-253. PubMed ID: 36414195
[TBL] [Abstract][Full Text] [Related]
12. Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on "Pseudovirus-like" Nanoparticles.
Gaikwad H; Li Y; Wang G; Li R; Dai S; Rester C; Kedl R; Saba L; Banda NK; Scheinman RI; Patrick C; Mallela KMG; Moghimi SM; Simberg D
ACS Nano; 2022 May; ():. PubMed ID: 35507641
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine.
Komori M; Morey AL; Quiñones-Molina AA; Fofana J; Romero L; Peters E; Matsuda K; Gummuluru S; Smith JF; Akahata W; Akiyama H
bioRxiv; 2023 Nov; ():. PubMed ID: 37961509
[TBL] [Abstract][Full Text] [Related]
14. Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate.
Karpenko LI; Rudometov AP; Sharabrin SV; Shcherbakov DN; Borgoyakova MB; Bazhan SI; Volosnikova EA; Rudometova NB; Orlova LA; Pyshnaya IA; Zaitsev BN; Volkova NV; Azaev MS; Zaykovskaya AV; Pyankov OV; Ilyichev AA
Vaccines (Basel); 2021 Jan; 9(2):. PubMed ID: 33494530
[TBL] [Abstract][Full Text] [Related]
15. Periodic Mesoporous Organosilica as a Nanoadjuvant for Subunit Vaccines Elicits Potent Antigen-Specific Germinal Center Responses by Activating Naive B Cells.
Li F; Feng X; Huang J; Zhang M; Liu W; Wang X; Zhu R; Wang X; Wang P; Yu B; Li W; Qiao ZA; Yu X
ACS Nano; 2023 Aug; 17(16):15424-15440. PubMed ID: 37552584
[TBL] [Abstract][Full Text] [Related]
16. Delivery of Experimental mRNA Vaccine Encoding the RBD of SARS-CoV-2 by Jet Injection.
Kisakov DN; Kisakova LA; Sharabrin SV; Yakovlev VA; Tigeeva EV; Borgoyakova MB; Starostina EV; Zaikovskaya AV; Rudometov AP; Rudometova NB; Karpenko LI; Ilyichev AA
Bull Exp Biol Med; 2024 Jun; ():. PubMed ID: 38896316
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of SARS-CoV-2 mRNA Vaccine Efficacy through the Application of TMSB10 UTR for Superior Antigen Presentation and Immune Activation.
Ding X; Zhou Y; He J; Zhao J; Li J
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675814
[TBL] [Abstract][Full Text] [Related]
18. RNA Combined with Nanoformulation to Advance Therapeutic Technologies.
Lima ES; Dos Santos D; Souza AL; Macedo ME; Bandeira ME; Junior SSS; Fiuza BSD; Rocha VPC; Dos Santos Fonseca LM; Nunes DDG; Hodel KVS; Machado BAS
Pharmaceuticals (Basel); 2023 Nov; 16(12):. PubMed ID: 38139761
[TBL] [Abstract][Full Text] [Related]
19. Design and Characterization of a New Formulation for the Delivery of COVID-19-mRNA Vaccine to the Nasal Mucosa.
Altay Benetti A; Tan EYZ; Chang ZW; Bae KH; Thwin MT; Muthuramalingam RPK; Liao KC; Wan Y; Ng LFP; Renia L; Liu J; Chen X; Yang YY; White KP; Pastorin G
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675792
[TBL] [Abstract][Full Text] [Related]
20. Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity.
Roth GA; Gale EC; Alcántara-Hernández M; Luo W; Axpe E; Verma R; Yin Q; Yu AC; Lopez Hernandez H; Maikawa CL; Smith AAA; Davis MM; Pulendran B; Idoyaga J; Appel EA
ACS Cent Sci; 2020 Oct; 6(10):1800-1812. PubMed ID: 33145416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
